Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

NICE Guidance - August 2017

The National Institute of Health and Care Excellence (NICE) have published new or updated guidance for the month of August 2017. This month there are three guidelines and three technology appraisals that impact upon primary care.

The Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women technology appraisal has been updated. The guidance on the use of etidronate for the primary prevention of osteoporotic fragility fractures in postmenopausal women has been withdrawn because etidronate is no longer marketed in the UK.

The Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women technology appraisal has also been updated. The guidance on the use of etidronate for the primary prevention of osteoporotic fragility fractures in postmenopausal women has been withdrawn because etidronate is no longer marketed in the UK.

The Bisphosphonates for treating osteoporosis technology appraisal has been published and partially updates both of the technology appraisals above.

The Developmental follow-up of children and young people born preterm guideline has been published and covers the developmental follow-up of babies, children and young people under 18 years who were born preterm (before 37+0 weeks of pregnancy). It explains the risk of different developmental problems and disorders, and specifies what extra assessments and support children born preterm might need during their growth and development.

The Fever in under 5s clinical guideline has been updated to include a cross-reference to the NICE guideline on sepsis.

The Nutrition support for adults clinical guideline has been updated to include links to resources in several of the recommendations.

Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.

Share 'NICE Guidance - August 2017' on Email Share 'NICE Guidance - August 2017' on Delicious Share 'NICE Guidance - August 2017' on Digg Share 'NICE Guidance - August 2017' on Facebook Share 'NICE Guidance - August 2017' on Google+ Share 'NICE Guidance - August 2017' on reddit Share 'NICE Guidance - August 2017' on StumbleUpon Share 'NICE Guidance - August 2017' on Twitter

atomic-wealth

No Comments to “NICE Guidance - August 2017”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,620 spam comments.

atomic-wealth
fond-illness
summer